Link between exposure to pollutants and type 2 diabetes

November 28, 2005

People exposed to high levels of persistent organochlorine pollutants (POPs), which are most likely to come from eating fatty fish such as salmon, might be at risk of developing diabetes. A study published today in the open access journal Environmental Health reveals that exposure to high levels of POPs, a family of toxic chemicals that includes polychlorinated biphenyls (PCBs) and the insecticide DDT, is associated with a high prevalence of type 2 diabetes mellitus in a population of fishermen and their wives. POPs are by-products of industrial and agricultural processes and are widespread in the environment.

Lars Rylander and colleagues from the University of Lund, Sweden, studied the incidence of type 2 diabetes in196 fishermen and 184 fishermen's wives, and analysed levels in their blood of the POP residue CB-153, and DDE, the main by-product of DDT. Levels of both residues reflect exposure to POPs.

Rylander et al.'s results show that 6% of men and 5% of women who took part in the study have diabetes. Those that were found to have type 2 diabetes have significantly higher blood levels of both CB-153 and DDE than non-diabetics in the group of fisherman and fisherman's wives, which suggests high exposure to POPs. A statistical analysis of the results shows that exposure to CB-153 and DDE is significantly associated with a high prevalence of diabetes.
-end-
Article: A cross-sectional study of the association between persistent organochlorine pollutants and diabetes
Lars Rylander, Anna Rignell-Hydbom and Lars Hagmar
Environmental Health: A Global Access Science Source, in press

BioMed Central

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.